PD-1 inhibitor as bridge therapy to liver transplantation?

Parissa Tabrizian; Sander S Florman; Myron E Schwartz

doi:10.1111/ajt.16448

PD-1 inhibitor as bridge therapy to liver transplantation?

Am J Transplant. 2021 May;21(5):1979-1980. doi: 10.1111/ajt.16448. Epub 2021 Jan 2.

Authors

Parissa Tabrizian¹, Sander S Florman¹, Myron E Schwartz¹

Affiliation

¹ Mount Sinai Medical Center, Recanati/Miller Transplantation Institute, New York, New York.

PMID: 33316117
DOI: 10.1111/ajt.16448

No abstract available

Keywords: cancer/malignancy/neoplasia; clinical research/practice; graft survival; immunobiology; liver disease: malignant; liver transplantation/hepatology.

Publication types

Letter

MeSH terms

Graft Rejection / prevention & control
Graft Survival
Immune Checkpoint Inhibitors
Liver Transplantation*
Prognosis
Risk Factors

Substances

Immune Checkpoint Inhibitors